Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey

<p>Abstract</p> <p>Background</p> <p>Shared decision-making and patients’ choice of interventions are areas of increasing importance, not least seen in the light of the fact that chronic conditions are increasing, interventions considered important for public health, an...

Full description

Bibliographic Details
Main Authors: Harmsen Charlotte, Støvring Henrik, Jarbøl Dorte, Nexøe Jørgen, Gyrd-Hansen Dorte, Nielsen Jesper, Edwards Adrian, Kristiansen Ivar
Format: Article
Language:English
Published: BMC 2012-08-01
Series:BMC Medical Informatics and Decision Making
Subjects:
Online Access:http://www.biomedcentral.com/1472-6947/12/89
id doaj-83d779ebc7b34eb7a24196758807c9f3
record_format Article
spelling doaj-83d779ebc7b34eb7a24196758807c9f32020-11-24T21:53:01ZengBMCBMC Medical Informatics and Decision Making1472-69472012-08-011218910.1186/1472-6947-12-89Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based surveyHarmsen CharlotteStøvring HenrikJarbøl DorteNexøe JørgenGyrd-Hansen DorteNielsen JesperEdwards AdrianKristiansen Ivar<p>Abstract</p> <p>Background</p> <p>Shared decision-making and patients’ choice of interventions are areas of increasing importance, not least seen in the light of the fact that chronic conditions are increasing, interventions considered important for public health, and still non-acceptance of especially risk-reducing treatments of cardiovascular diseases (CVD) is prevalent. A better understanding of patients’ medication-taking behavior is needed and may be reached by studying the reasons why people accept or decline medication recommendations. The aim of this paper was to identify factors that may influence people’s decisions and reasoning for accepting or declining a cardiovascular preventive medication offer.</p> <p>Methods</p> <p>From a random sample of 4,000 people aged 40–59 years in a Danish population, 1,169 participants were asked to imagine being at increased risk of cardiovascular disease and being offered a preventive medication. After receiving ‘complete’ information about effectiveness of the medication they were asked whether they would accept medication. Finally, they were asked about reasons for the decision.</p> <p>Results</p> <p>A total of 725 (67%) of 1,082 participants accepted the medication offer. Even quite large effects of medication (up to 8 percentage points absolute risk reduction) had a smaller impact on acceptance to medication than personal experience with cardiovascular disease. Furthermore, increasing age of the participant and living with a partner were significantly associated with acceptance. Some 45% of the respondents accepting justified their choice as being for health reasons, and they were more likely to be women, live alone, have higher income and higher education levels. Among those who did not accept the medication offer, 56% indicated that they would rather prefer to change lifestyle.</p> <p>Conclusions</p> <p>Medication effectiveness seems to have a moderate influence on people’s decisions to accept preventive medication, while factors such as personal experience with cardiovascular disease may have an equally strong or stronger influence, indicating that practitioners could do well to carefully identify the reasons for their patients’ treatment decisions.</p> http://www.biomedcentral.com/1472-6947/12/89Decision-makingRisk assessmentRisk communicationPreventive health servicesPrimary preventionCardiovascular diseaseHealth behavior
collection DOAJ
language English
format Article
sources DOAJ
author Harmsen Charlotte
Støvring Henrik
Jarbøl Dorte
Nexøe Jørgen
Gyrd-Hansen Dorte
Nielsen Jesper
Edwards Adrian
Kristiansen Ivar
spellingShingle Harmsen Charlotte
Støvring Henrik
Jarbøl Dorte
Nexøe Jørgen
Gyrd-Hansen Dorte
Nielsen Jesper
Edwards Adrian
Kristiansen Ivar
Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
BMC Medical Informatics and Decision Making
Decision-making
Risk assessment
Risk communication
Preventive health services
Primary prevention
Cardiovascular disease
Health behavior
author_facet Harmsen Charlotte
Støvring Henrik
Jarbøl Dorte
Nexøe Jørgen
Gyrd-Hansen Dorte
Nielsen Jesper
Edwards Adrian
Kristiansen Ivar
author_sort Harmsen Charlotte
title Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
title_short Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
title_full Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
title_fullStr Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
title_full_unstemmed Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
title_sort medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey
publisher BMC
series BMC Medical Informatics and Decision Making
issn 1472-6947
publishDate 2012-08-01
description <p>Abstract</p> <p>Background</p> <p>Shared decision-making and patients’ choice of interventions are areas of increasing importance, not least seen in the light of the fact that chronic conditions are increasing, interventions considered important for public health, and still non-acceptance of especially risk-reducing treatments of cardiovascular diseases (CVD) is prevalent. A better understanding of patients’ medication-taking behavior is needed and may be reached by studying the reasons why people accept or decline medication recommendations. The aim of this paper was to identify factors that may influence people’s decisions and reasoning for accepting or declining a cardiovascular preventive medication offer.</p> <p>Methods</p> <p>From a random sample of 4,000 people aged 40–59 years in a Danish population, 1,169 participants were asked to imagine being at increased risk of cardiovascular disease and being offered a preventive medication. After receiving ‘complete’ information about effectiveness of the medication they were asked whether they would accept medication. Finally, they were asked about reasons for the decision.</p> <p>Results</p> <p>A total of 725 (67%) of 1,082 participants accepted the medication offer. Even quite large effects of medication (up to 8 percentage points absolute risk reduction) had a smaller impact on acceptance to medication than personal experience with cardiovascular disease. Furthermore, increasing age of the participant and living with a partner were significantly associated with acceptance. Some 45% of the respondents accepting justified their choice as being for health reasons, and they were more likely to be women, live alone, have higher income and higher education levels. Among those who did not accept the medication offer, 56% indicated that they would rather prefer to change lifestyle.</p> <p>Conclusions</p> <p>Medication effectiveness seems to have a moderate influence on people’s decisions to accept preventive medication, while factors such as personal experience with cardiovascular disease may have an equally strong or stronger influence, indicating that practitioners could do well to carefully identify the reasons for their patients’ treatment decisions.</p>
topic Decision-making
Risk assessment
Risk communication
Preventive health services
Primary prevention
Cardiovascular disease
Health behavior
url http://www.biomedcentral.com/1472-6947/12/89
work_keys_str_mv AT harmsencharlotte medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
AT støvringhenrik medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
AT jarbøldorte medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
AT nexøejørgen medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
AT gyrdhansendorte medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
AT nielsenjesper medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
AT edwardsadrian medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
AT kristiansenivar medicationeffectivenessmaynotbethemajorreasonforacceptingcardiovascularpreventivemedicationapopulationbasedsurvey
_version_ 1725873414412959744